Clinical Trials Logo

Clinical Trial Summary

Near infrared spectroscpy is a validated method of evaluating cerebral blood flow. The aim in this pilot study to explore its use in children with moyamoya disease.


Clinical Trial Description

Moyamoya disease is a cerebrovascular condition in which there is chronic brain hypoperfusion. As surgery can possibly augment brain blood flow, a method for evalutaing cerebrovascualr reserve would be helpful in selecting patients for intervention. Near infrared spectroscopy (NIRS) is a validated non-invasive method of evaluating cerebral blood flow. We aim to investigate the feasibility and tolerability of using NIRS haemodynamic reserve in children with moyamoya and controls by evaluating cerebral blood flow in the baseline state and after breath-holding. Feasibility will be assessed by how many successful studies are carried out. Tolerability will be assessed by asking children some simple questions about their experience. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05160454
Study type Interventional
Source Great Ormond Street Hospital for Children NHS Foundation Trust
Contact
Status Suspended
Phase N/A
Start date February 14, 2018
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT00629915 - The Role of Cerebral Hemodynamics in Moyamoya Disease
Active, not recruiting NCT02319980 - The Adult Hemorrhagic Moyamoya Surgery Study Phase 3
Not yet recruiting NCT06330818 - Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients N/A
Enrolling by invitation NCT04240119 - Angiogenic Markers in Cerebrovascular Disease (ANFIS)
Completed NCT02434302 - Characteristics and Outcomes of Childhood Moyamoya in the UK